Read more stories about
Montana Biotech >>

MATR Sponsor:


MATR Supporters:

GSK to open clinical data vaults to scientists via website

October 14, 2012View for printing

GlaxoSmithKline ($GSK) committed to provide researchers with unmatched access to patient-level data from its clinical trials--including studies that failed. The move is among several steps the London-based drug giant announced today to promote open innovation and collaboration with external groups. Yet commentators are skeptical about whether fellow drugmakers will be as bold in opening their data vaults to outsiders.

By Ryan McBride

Full Story: http://www.fiercebiotechit.com/story ... /2012-10-11
No reader comments so far. Be the first to comment by clicking the button below.





Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.


E-mail this page to a friend!